{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Rucaparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Rucaparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Rucaparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "rucaparib",
    "trial_2_text": "Rucaparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Rucaparib Supplement: 60 participants will take Rucaparib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Rucaparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Rucaparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "189": 0.26396244764328003,
      "87": 0.2609926760196686,
      "78": 0.23868289589881897,
      "188": 0.20635199546813965,
      "123": 0.1981484293937683,
      "17": 0.19027356803417206,
      "68": 0.18622662127017975,
      "20": 0.17180795967578888,
      "77": 0.1639673262834549,
      "177": 0.16097323596477509,
      "9": 0.15569978952407837,
      "173": 0.15514323115348816,
      "49": 0.15011784434318542,
      "37": 0.1392544060945511,
      "67": 0.13912507891654968,
      "101": 0.13157996535301208,
      "79": 0.1309913843870163,
      "350": 0.13071948289871216,
      "21": 0.12863656878471375,
      "243": 0.12844057381153107,
      "228": 0.12752608954906464,
      "200": 0.12381092458963394,
      "193": 0.12277350574731827,
      "2": 0.11734616756439209,
      "64": 0.11699425429105759,
      "46": 0.11590554565191269,
      "114": 0.11075674742460251,
      "14": 0.11022836714982986,
      "261": 0.10380514711141586,
      "72": 0.10256434977054596,
      "29": 0.09865763783454895,
      "194": 0.09864784777164459,
      "239": 0.09786447882652283,
      "179": 0.09260304272174835,
      "104": 0.08870179206132889,
      "38": 0.08686497807502747,
      "126": 0.08199433982372284,
      "139": 0.07883533835411072,
      "102": 0.07780316472053528,
      "86": 0.07615139335393906,
      "5": 0.07588531821966171,
      "341": 0.07500593364238739,
      "85": 0.07417473196983337,
      "100": 0.07278881222009659,
      "355": 0.07083702087402344,
      "122": 0.06961340457201004,
      "131": 0.06850995123386383,
      "27": 0.06776390969753265,
      "186": 0.06618662923574448,
      "151": 0.06593038141727448,
      "191": 0.06535946577787399,
      "204": 0.06463789194822311,
      "116": 0.06410440057516098,
      "144": 0.06313111633062363,
      "28": 0.060909610241651535,
      "234": 0.06049276515841484,
      "82": 0.05944874510169029,
      "36": 0.057230982929468155,
      "396": 0.05689200013875961,
      "132": 0.056486617773771286,
      "18": 0.05633943900465965,
      "30": 0.05605228990316391,
      "69": 0.05565771088004112,
      "466": 0.05556510016322136,
      "441": 0.054671596735715866,
      "249": 0.054557643830776215,
      "180": 0.054213568568229675,
      "76": 0.053694743663072586,
      "147": 0.053668901324272156,
      "212": 0.053458135575056076,
      "35": 0.05315728858113289,
      "1": 0.05252300575375557,
      "166": 0.05241271108388901,
      "33": 0.052273303270339966,
      "218": 0.05209667235612869,
      "154": 0.0520344153046608,
      "282": 0.05160113424062729,
      "61": 0.05110403150320053,
      "454": 0.05083346366882324,
      "297": 0.050756122916936874,
      "508": 0.0500856451690197,
      "97": 0.049662988632917404,
      "130": 0.0482807494699955,
      "92": 0.04732777178287506,
      "288": 0.04677078127861023,
      "262": 0.046309713274240494,
      "98": 0.04568428546190262,
      "164": 0.04553782567381859,
      "286": 0.04543715715408325,
      "422": 0.04487137869000435,
      "211": 0.04481397941708565,
      "276": 0.04381641000509262,
      "89": 0.043414440006017685,
      "361": 0.043359581381082535,
      "371": 0.0430564247071743,
      "136": 0.04268351197242737,
      "96": 0.04221620783209801,
      "363": 0.0420418344438076,
      "382": 0.0417790450155735,
      "345": 0.04125267267227173
    },
    "trial_2_ae": {
      "189": 0.26396244764328003,
      "87": 0.2609926760196686,
      "78": 0.23868289589881897,
      "188": 0.20635199546813965,
      "123": 0.1981484293937683,
      "17": 0.19027356803417206,
      "68": 0.18622662127017975,
      "20": 0.17180795967578888,
      "77": 0.1639673262834549,
      "177": 0.16097323596477509,
      "9": 0.15569978952407837,
      "173": 0.15514323115348816,
      "49": 0.15011784434318542,
      "37": 0.1392544060945511,
      "67": 0.13912507891654968,
      "101": 0.13157996535301208,
      "79": 0.1309913843870163,
      "350": 0.13071948289871216,
      "21": 0.12863656878471375,
      "243": 0.12844057381153107,
      "228": 0.12752608954906464,
      "200": 0.12381092458963394,
      "193": 0.12277350574731827,
      "2": 0.11734616756439209,
      "64": 0.11699425429105759,
      "46": 0.11590554565191269,
      "114": 0.11075674742460251,
      "14": 0.11022836714982986,
      "261": 0.10380514711141586,
      "72": 0.10256434977054596,
      "29": 0.09865763783454895,
      "194": 0.09864784777164459,
      "239": 0.09786447882652283,
      "179": 0.09260304272174835,
      "104": 0.08870179206132889,
      "38": 0.08686497807502747,
      "126": 0.08199433982372284,
      "139": 0.07883533835411072,
      "102": 0.07780316472053528,
      "86": 0.07615139335393906,
      "5": 0.07588531821966171,
      "341": 0.07500593364238739,
      "85": 0.07417473196983337,
      "100": 0.07278881222009659,
      "355": 0.07083702087402344,
      "122": 0.06961340457201004,
      "131": 0.06850995123386383,
      "27": 0.06776390969753265,
      "186": 0.06618662923574448,
      "151": 0.06593038141727448,
      "191": 0.06535946577787399,
      "204": 0.06463789194822311,
      "116": 0.06410440057516098,
      "144": 0.06313111633062363,
      "28": 0.060909610241651535,
      "234": 0.06049276515841484,
      "82": 0.05944874510169029,
      "36": 0.057230982929468155,
      "396": 0.05689200013875961,
      "132": 0.056486617773771286,
      "18": 0.05633943900465965,
      "30": 0.05605228990316391,
      "69": 0.05565771088004112,
      "466": 0.05556510016322136,
      "441": 0.054671596735715866,
      "249": 0.054557643830776215,
      "180": 0.054213568568229675,
      "76": 0.053694743663072586,
      "147": 0.053668901324272156,
      "212": 0.053458135575056076,
      "35": 0.05315728858113289,
      "1": 0.05252300575375557,
      "166": 0.05241271108388901,
      "33": 0.052273303270339966,
      "218": 0.05209667235612869,
      "154": 0.0520344153046608,
      "282": 0.05160113424062729,
      "61": 0.05110403150320053,
      "454": 0.05083346366882324,
      "297": 0.050756122916936874,
      "508": 0.0500856451690197,
      "97": 0.049662988632917404,
      "130": 0.0482807494699955,
      "92": 0.04732777178287506,
      "288": 0.04677078127861023,
      "262": 0.046309713274240494,
      "98": 0.04568428546190262,
      "164": 0.04553782567381859,
      "286": 0.04543715715408325,
      "422": 0.04487137869000435,
      "211": 0.04481397941708565,
      "276": 0.04381641000509262,
      "89": 0.043414440006017685,
      "361": 0.043359581381082535,
      "371": 0.0430564247071743,
      "136": 0.04268351197242737,
      "96": 0.04221620783209801,
      "363": 0.0420418344438076,
      "382": 0.0417790450155735,
      "345": 0.04125267267227173
    }
  },
  "safety": {
    "trial_1_safety": 0.36801865696907043,
    "trial_2_safety": 0.36801865696907043
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47856318950653076
  }
}